[Vascular accidents of estrogen therapy for prostatic cancer metastases].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D002741:Chlorotrianisene / Q000009:adverse effects; D004054:Diethylstilbestrol / Q000009:adverse effects; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D004967:Estrogens; D002741:Chlorotrianisene; D004054:Diethylstilbestrol
Accidents vasculaire de l'oestrogénothérapie dans les métastases du cancer prostatique